The insurance industry is hitting back at a new campaign that aims to make a point that medical management techniques, like step therapy and prior authorization, impair consumer access to medication. Officials with America's Health Insurance Plans suggest the campaign is yet another thinly veiled attempt by the pharmaceutical industry to divert attention from drug makers' role in skyrocketing costs of drugs by blaming other stakeholders. At issue is a survey released last week by a newly launched health advocacy...